Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney

NCT02351427 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT02351427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney
Lead sponsor
Asan Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2015
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation